Erasca, Inc. (ERAS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $4.5 billion, Erasca, Inc. is a mid-cap company. The stock currently trades at $14.53, up 6.37% today, with a 52-week range of $1.01–$14.63.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.69 | $-0.69 | +16.9% | |
| 2023 | $-0.83 | $-0.83 | +58.3% | |
| 2022 | $-1.99 | $-1.99 | — | |
| 2021 | — | — | — |